AGSM has focused on early stage investments in small, privately held companies with revenues of approximately $500K or more.
OUR HISTORY
AGSM seeks to generate superior returns through the long-term capital appreciation of its equity investments.
WHAT WE DO
OUR PEOPLE
MEET OUR KNOWLEDGABLE TEAM
OUR PORTFOLIO COMPANIES
INDIGO Biosciences & Bertin Pharma Sign European Distribution Agreement
November 15, 2016
INDIGO Biosciences, the recognized industry-leader in Nuclear Receptor research, and Bertin Pharma have announced the completion of a European distribution agreement. Over 40 product references for studying nuclear receptors are now available for European researchers doing their work in drug discovery and toxicology. These innovative tools are ....
INDIGO Hires Scott Youells, M.Sc. as Director of Sales
November 14, 2016
State College, PA (November 14, 2016) INDIGO Biosciences is pleased to announce that Scott Youells, M.Sc. has joined INDIGO Biosciences as Director of Sales. Scott comes to INDIGO with more than 15 years of biotech experience, having spent 10 years in a major research laboratory and 6 years in technical sales. His experience in pharmaceutical research, development synthesis, and screening techniques are of critical importance in supporting INDIGO customers.